SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    0 We conducted a retrospective study to evaluate the clinicopathologic features and prognostic factors associated with primary sinonasal malignant melanoma .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    0 We_PPIS2 conducted_VVD a_AT1 retrospective_JJ study_NN1 to_TO evaluate_VVI the_AT clinicopathologic_JJ features_NN2 and_CC prognostic_JJ factors_NN2 associated_VVN with_IW primary_JJ sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    1 We reviewed the records of 10 patients -- 7 men and 3 women , aged 35 to 70 years ( mean : 51.4 ) -- who had been treated at our referral center over a 9-year period .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    1 We_PPIS2 reviewed_VVD the_AT records_NN2 of_IO 10_MC patients_NN2 --_NN1_JJ 7_MC men_NN2 and_CC 3_MC women_NN2 ,_Y aged_II 35_MC to_II 70_MC years_NNT2 (_Y mean_VV0 :_Y 51.4_MC )_Y --_NN1 who_PNQS had_VHD been_VBN treated_VVN at_II our_APPGE referral_NN1 center_NN1 over_II_RP a_AT1 9-year_JJ_NNT1 period_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    2 The tumors were located in the nasal cavity in 7 patients and in a paranasal sinus in the other 3 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    2 The_AT tumors_NN2 were_VBDR located_VVN in_II the_AT nasal_JJ cavity_NN1 in_II 7_MC patients_NN2 and_CC in_II a_AT1 paranasal_NN1_JJ@ sinus_NN1 in_II the_AT other_JJ_NN1@ 3_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    3 Medial maxillectomy was performed in 4 patients , wide local excision in 3 , and endoscopic excision in 2 ; the remaining patient , who had presented with a liver metastasis , received chemotherapy and palliative local radiotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    3 Medial_JJ maxillectomy_NN1 was_VBDZ performed_VVN in_II 4_MC patients_NN2 ,_Y wide_JJ_RR@ local_JJ excision_NN1 in_II 3_MC ,_Y and_CC endoscopic_JJ excision_NN1 in_II 2_MC ;_Y the_AT remaining_JJ patient_NN1_JJ ,_Y who_PNQS had_VHD presented_VVN with_IW a_AT1 liver_NN1 metastasis_NN1 ,_Y received_VVD_JJ@_VVN chemotherapy_NN1 and_CC palliative_JJ local_JJ radiotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    4 Two patients who presented with a neck node metastasis also underwent concurrent radical neck dissection .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    4 Two_MC patients_NN2 who_PNQS presented_VVD with_IW a_AT1 neck_NN1 node_NN1 metastasis_NN1 also_RR underwent_VVD concurrent_JJ radical_JJ_NN1 neck_NN1 dissection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    5 Follow-up ranged from 8 to 70 months ( median : 25 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    5 Follow-up_NN1 ranged_VVN_VVD from_II 8_MC to_II 70_MC months_NNT2 (_Y median_NN1_JJ :_Y 25_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    6 Only 4 patients remained alive through the duration of follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    6 Only_RR 4_MC patients_NN2 remained_VVD_VVN alive_JJ through_II the_AT duration_NN1 of_IO follow-up_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    7 The 2- and 5-year survival rates were 60 and 40% , respectively .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    7 The_AT 2-_NN1_JJ and_CC 5-year_JJ survival_NN1 rates_NN2 were_VBDR 60_MC and_CC 40%_NNU ,_Y respectively_RR ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    8 Based on the findings of our small study , we conclude that primary sinonasal malignant melanoma carries cause of death in our series was a distant metastasis ( n = 5 ) despite adequate locoregional control in most cases .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    8 Based_VVN on_II the_AT findings_NN2 of_IO our_APPGE small_JJ study_NN1 ,_Y we_PPIS2 conclude_VV0 that_CST_DD1 primary_JJ_NN1 sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 carries_VVZ cause_NN1 of_IO death_NN1 in_II our_APPGE series_NN was_VBDZ a_AT1 distant_JJ metastasis_NN1 (_Y n_ZZ1 =_FO 5_MC )_Y despite_II adequate_JJ locoregional_JJ control_NN1 in_II most_DAT cases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0    9 This finding confirms the aggressive nature of this disease .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0    9 This_DD1 finding_NN1 confirms_VVZ the_AT aggressive_JJ nature_NN1 of_IO this_DD1 disease_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   10 Other factors that appeared to be associated with a poor prognosis were ( 1 ) older age , ( 2 ) a primary tumor location in a paranasal sinus , ( 3 ) an advanced tumor stage , ( 4 ) an external approach to surgery , and ( 5 ) the absence of adjuvant radiotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   10 Other_JJ factors_NN2 that_CST appeared_VVD to_TO be_VBI associated_VVN with_IW a_AT1 poor_JJ prognosis_NN1 were_VBDR (_Y 1_MC1 )_Y older_JJR age_NN1 ,_Y (_Y 2_MC )_Y a_AT1 primary_JJ_NN1 tumor_NN1 location_NN1 in_II a_AT1 paranasal_NN1_JJ@ sinus_NN1 ,_Y (_Y 3_MC )_Y an_AT1 advanced_JJ tumor_NN1 stage_NN1 ,_Y (_Y 4_MC )_Y an_AT1 external_JJ approach_NN1 to_II surgery_NN1 ,_Y and_CC (_Y 5_MC )_Y the_AT absence_NN1 of_IO adjuvant_JJ_NN1 radiotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   11 Mucosal melanomas were first described by Weber in 1859. n1 Primary sinonasal malignant melanoma is a rare lesion , with a reported annual incidence of 0.018 per 100,000 population. n2 Mucosal malignant melanoma has a different clinical course and outcome than its cutaneous counterpart .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   11 Mucosal_JJ melanomas_NN2 were_VBDR first_MD described_VVN by_II Weber_NP1 in_II 1859._MC n1_FO Primary_JJ_NN1 sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 is_VBZ a_AT1 rare_JJ lesion_NN1 ,_Y with_IW a_AT1 reported_JJ@ annual_JJ incidence_NN1 of_IO 0.018_MC per_II 100,000_MC population._NNU n2_FO Mucosal_JJ malignant_JJ_NN1 melanoma_NN1 has_VHZ a_AT1 different_JJ clinical_JJ course_NN1 and_CC outcome_NN1 than_CSN its_Z' cutaneous_JJ counterpart_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   12 Sinonasal malignant melanoma , in turn , has a different clinical course and outcome than malignant melanoma in other mucosal sites. ( n3-n5 ) For example , sinonasal malignant melanoma has a more aggressive behavior and is associated with a poorer prognosis than oral cavity melanoma despite aggressive surgical treatment and postoperative irradiation .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   12 Sinonasal_NN1_JJ@_NP1@ malignant_NN1_JJ melanoma_NN1 ,_Y in_II turn_NN1 ,_Y has_VHZ a_AT1 different_JJ clinical_JJ course_NN1 and_CC outcome_NN1 than_CSN malignant_JJ melanoma_NN1 in_II other_JJ mucosal_JJ sites._NNU (_Y n3-n5_NN1_JJ )_Y For_REX21 example_REX22 ,_Y sinonasal_JJ@_NN1 malignant_JJ_NN1 melanoma_NN1 has_VHZ a_AT1 more_RGR aggressive_JJ behavior_NN1 and_CC is_VBZ associated_VVN with_IW a_AT1 poorer_JJR prognosis_NN1 than_CSN oral_JJ cavity_NN1 melanoma_NN1 despite_II aggressive_JJ surgical_JJ treatment_NN1 and_CC postoperative_JJ irradiation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   13 The poorer .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   13 The_AT poorer_JJR ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   14 The relative inaccessibility of the mucosa to self-examination often delays diagnosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   14 The_AT relative_JJ_NN1 inaccessibility_NN1 of_IO the_AT mucosa_NN1 to_II self-examination_NN1_JJ often_RR delays_NN2_VVZ% diagnosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   15 Also , morbidity and mortality may be increased as a result of the proximity of these tumors to vital structures such as the orbit and brain .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   15 Also_RR ,_Y morbidity_NN1 and_CC mortality_NN1 may_VM be_VBI increased_VVN as_II a_AT1 result_NN1 of_IO the_AT proximity_NN1 of_IO these_DD2 tumors_NN2 to_II vital_JJ structures_NN2 such_II21 as_II22 the_AT orbit_NN1 and_CC brain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   16 The differential diagnosis should include carcinoma , lymphoma , Sarcoma , and olfactory neuroblastoma .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   16 The_AT differential_JJ_NN1 diagnosis_NN1 should_VM include_VVI carcinoma_NN1 ,_Y lymphoma_NN1 ,_Y Sarcoma_NP1 ,_Y and_CC olfactory_JJ neuroblastoma_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   17 Because of the small number of primary sinonasal malignant melanomas that have been reported in the literature , little new information has been generated about this entity , and treatments have varied over the years .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   17 Because_II21 of_II22 the_AT small_JJ number_NN1 of_IO primary_JJ_NN1 sinonasal_NN1_JJ@ malignant_NN1_JJ melanomas_NN2 that_CST have_VH0 been_VBN reported_VVN in_II the_AT literature_NN1 ,_Y little_RR_DA1_JJ new_JJ information_NN1 has_VHZ been_VBN generated_VVN about_II this_DD1 entity_NN1 ,_Y and_CC treatments_NN2 have_VH0 varied_VVN over_II_RP the_AT years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   18 In this article , we describe our retrospective study of the clinicopathologic features of and prognostic factors associated with cases of primary sinonasal malignant melanoma that were managed at our institution .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   18 In_II this_DD1 article_NN1 ,_Y we_PPIS2 describe_VV0 our_APPGE retrospective_JJ study_NN1 of_IO the_AT clinicopathologic_JJ features_NN2 of_IO and_CC prognostic_JJ factors_NN2 associated_VVN with_IW cases_NN2 of_IO primary_JJ_NN1 sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 that_CST were_VBDR managed_VVN at_II our_APPGE institution_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   19 Patients and methods We reviewed the medical records of all patients who had been treated for primary head and neck malignant melanoma at our institution between January 1996 and December 2004 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   19 Patients_NN2 and_CC methods_NN2 We_PPIS2 reviewed_VVD the_AT medical_JJ records_NN2 of_IO all_DB patients_NN2 who_PNQS had_VHD been_VBN treated_VVN for_IF primary_JJ_NN1 head_NN1 and_CC neck_NN1_VV0@ malignant_NN1_JJ melanoma_NN1 at_II our_APPGE institution_NN1 between_II January_NPM1 1996_MC and_CC December_NPM1 2004_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   20 We found 90 such cases .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   20 We_PPIS2 found_VVD 90_MC such_DA cases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   21 All patients had undergone clinical examination of the neck and abdomen , nasal endoscopy to determine the extent of the tumor , and contrast-enhanced computed tomography of the nose , been performed in those patients who had been suspected of having intracranial extension .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   21 All_DB patients_NN2 had_VHD undergone_VVN clinical_JJ examination_NN1 of_IO the_AT neck_NN1 and_CC abdomen_NN1 ,_Y nasal_JJ endoscopy_NN1 to_TO determine_VVI the_AT extent_NN1 of_IO the_AT tumor_NN1 ,_Y and_CC contrast-enhanced_JJ_NN1 computed_JJ@_VVD_VVN tomography_NN1 of_IO the_AT nose_NN1 ,_Y been_VBN performed_VVN in_II those_DD2 patients_NN2 who_PNQS had_VHD been_VBN suspected_VVN of_IO having_VHG intracranial_JJ extension_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   22 All patients had undergone ultrasonography of the abdomen and a bone scan to look for distant metastases .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   22 All_DB patients_NN2 had_VHD undergone_VVN ultrasonography_NN1 of_IO the_AT abdomen_NN1 and_CC a_AT1 bone_NN1 scan_NN1_VV0 to_TO look_VVI for_IF distant_JJ metastases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   23 We then narrowed our population to those who had presented with a primary malignant melanoma of the nasal cavity or paranasal sinuses .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   23 We_PPIS2 then_RT narrowed_VVD our_APPGE population_NN1 to_II those_DD2 who_PNQS had_VHD presented_VVN with_IW a_AT1 primary_JJ malignant_JJ_NN1 melanoma_NN1 of_IO the_AT nasal_JJ cavity_NN1 or_CC paranasal_NN1_JJ@ sinuses_NN2_VVZ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   24 Patients with ocular melanoma that had extended into the nasal cavity were not included in our analysis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   24 Patients_NN2 with_IW ocular_JJ melanoma_NN1 that_CST had_VHD extended_VVN into_II the_AT nasal_JJ cavity_NN1 were_VBDR not_XX included_VVN in_II our_APPGE analysis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   25 The primary nature of the presenting sinonasal malignant melanoma had been confirmed by clinical data -- specifically , ( 1 ) the absence of a history of melanoma at any other site in the body and ( 2 ) an absence of evidence of a metastatic melanoma from an extramucosal site .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   25 The_AT primary_JJ_NN1 nature_NN1 of_IO the_AT presenting_NN1@_VVG sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 had_VHD been_VBN confirmed_VVN by_II clinical_JJ data_NN --_NN1_JJ specifically_RR ,_Y (_Y 1_MC1 )_Y the_AT absence_NN1 of_IO a_AT1 history_NN1 of_IO melanoma_NN1 at_II any_DD other_JJ site_NN1 in_II the_AT body_NN1 and_CC (_Y 2_MC )_Y an_AT1 absence_NN1 of_IO evidence_NN1 of_IO a_AT1 metastatic_JJ melanoma_NN1 from_II an_AT1 extramucosal_NN1_JJ@ site_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   26 In all , 10 patients -- 7 men and 3 women , aged 35 to 70 years ( mean : 51.4 ) -- met our inclusion criteria .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   26 In_II all_DB ,_Y 10_MC patients_NN2 --_NN1_JJ 7_MC men_NN2 and_CC 3_MC women_NN2 ,_Y aged_II 35_MC to_II 70_MC years_NNT2 (_Y mean_VV0 :_Y 51.4_MC )_Y --_NN1 met_VVD_VVN our_APPGE inclusion_NN1 criteria_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   27 In addition to demographic data , we compiled information on presenting symptoms , the site of the primary tumor , the presence of any nodal or distant metastasis at presentation , the tumor stage , initial treatment , and its treatment , outcomes , and histopathologic features .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   27 In_II31 addition_II32 to_II33 demographic_JJ data_NN ,_Y we_PPIS2 compiled_VVD information_NN1 on_II presenting_VVG symptoms_NN2 ,_Y the_AT site_NN1 of_IO the_AT primary_JJ_NN1 tumor_NN1 ,_Y the_AT presence_NN1 of_IO any_DD nodal_JJ or_CC distant_JJ metastasis_NN1 at_II presentation_NN1 ,_Y the_AT tumor_NN1 stage_NN1 ,_Y initial_JJ_NN1 treatment_NN1 ,_Y and_CC its_Z' treatment_NN1 ,_Y outcomes_NN2 ,_Y and_CC histopathologic_JJ features_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   28 Presenting features .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   28 Presenting_VVG features_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   29 The presenting symptoms were nasal obstruction in 6 patients , epistaxis in 2 , epiphora in 2 , neck swelling in 2 , and diplopia with a decrease in vision in 1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   29 The_AT presenting_NN1@_VVG symptoms_NN2 were_VBDR nasal_JJ obstruction_NN1 in_II 6_MC patients_NN2 ,_Y epistaxis_NN1 in_II 2_MC ,_Y epiphora_NN1 in_II 2_MC ,_Y neck_NN1_VV0@ swelling_VVG in_II 2_MC ,_Y and_CC diplopia_NN1 with_IW a_AT1 decrease_NN1 in_II vision_NN1 in_II 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   30 The primary tumor was seen in the nasal cavity in 7 patients and in a paranasal sinus in 3 ( 2 maxillary sinus and 1 ethmoid sinus ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   30 The_AT primary_JJ_NN1 tumor_NN1 was_VBDZ seen_VVN in_II the_AT nasal_JJ cavity_NN1 in_II 7_MC patients_NN2 and_CC in_II a_AT1 paranasal_NN1_JJ@ sinus_NN1 in_II 3_MC (_Y 2_MC maxillary_JJ sinus_NN1 and_CC 1_MC1 ethmoid_JJ_NN1 sinus_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   31 Two patients presented with a neck node metastasis and 1 with a liver metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   31 Two_MC patients_NN2 presented_VVN_VVD with_IW a_AT1 neck_NN1 node_NN1 metastasis_NN1 and_CC 1_MC1 with_IW a_AT1 liver_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   32 Six patients had a clinical stage I tumor , 2 had a stage II tumor , and 1 patient each had a stage III and IV tumor ( table ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   32 Six_MC patients_NN2 had_VHD a_AT1 clinical_JJ stage_NN1 I_MC1% tumor_NN1 ,_Y 2_MC had_VHD a_AT1 stage_NN1 II_MC tumor_NN1 ,_Y and_CC 1_MC1 patient_NN1_JJ each_DD1 had_VHD a_AT1 stage_NN1 III_MC and_CC IV_MC_JJ% tumor_NN1 (_Y table_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   33 Initial treatment .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   33 Initial_JJ_NN1 treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   34 Nine patients had undergone surgical excision of the primary tumor -- 7 via an external approach and 2 via an endoscopic approach .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   34 Nine_MC patients_NN2 had_VHD undergone_VVN surgical_JJ excision_NN1 of_IO the_AT primary_JJ_NN1 tumor_NN1 --_NN1 7_MC via_II an_AT1 external_JJ approach_NN1 and_CC 2_MC via_II an_AT1 endoscopic_JJ approach_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   35 The remaining patient ( patient 5 ) , who had presented with a liver metastasis , received chemotherapy and palliative local radiotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   35 The_AT remaining_JJ patient_NN1 (_Y patient_NN1_JJ 5_MC )_Y ,_Y who_PNQS had_VHD presented_VVN with_IW a_AT1 liver_NN1 metastasis_NN1 ,_Y received_VVD_JJ@_VVN chemotherapy_NN1 and_CC palliative_JJ local_JJ radiotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   36 The 7 external procedures included a medial maxillectomy in 4 patients and wide local excision in 3 patients ( table ) at presentation also underwent neck dissection concurrently with excision of the primary tumor .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   36 The_AT 7_MC external_JJ procedures_NN2 included_VVD_VVN a_AT1 medial_JJ maxillectomy_NN1 in_II 4_MC patients_NN2 and_CC wide_JJ_RR@ local_JJ excision_NN1 in_II 3_MC patients_NN2 (_Y table_NN1 )_Y at_II presentation_NN1 also_RR underwent_VVD neck_NN1 dissection_NN1 concurrently_RR with_IW excision_NN1 of_IO the_AT primary_JJ_NN1 tumor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   37 Follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   37 Follow-up_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   38 Patients were kept on a regular follow-up schedule after treatment .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   38 Patients_NN2 were_VBDR kept_VVN on_II a_AT1 regular_JJ follow-up_JJ_NN1 schedule_NN1 after_II_CS treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   39 Follow-up ranged from 8 to 70 months ( median : 25 ) ( table ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   39 Follow-up_NN1 ranged_VVN_VVD from_II 8_MC to_II 70_MC months_NNT2 (_Y median_NN1_JJ :_Y 25_MC )_Y (_Y table_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   40 Total follow-up was calculated in months from the date of diagnosis to the last recorded encounter .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   40 Total_JJ_NN1 follow-up_NN1 was_VBDZ calculated_VVN in_II months_NNT2 from_II the_AT date_NN1 of_IO diagnosis_NN1 to_II the_AT last_MD recorded_JJ@_VVD_VVN encounter_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   41 Sequelae .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   41 Sequelae_NN2_NP1@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   42 Following initial surgery , 3 patients developed a local recurrence , 2 developed a neck node metastasis , and 4 developed a distant metastasis ( 2 lung , 1 spinal cord , and 1 liver ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   42 Following_VVG_II@_JJ@ initial_JJ_NN1 surgery_NN1 ,_Y 3_MC patients_NN2 developed_VVD_VVN a_AT1 local_JJ recurrence_NN1 ,_Y 2_MC developed_VVD_VVN a_AT1 neck_NN1 node_NN1 metastasis_NN1 ,_Y and_CC 4_MC developed_VVD_VVN a_AT1 distant_JJ metastasis_NN1 (_Y 2_MC lung_NN1 ,_Y 1_MC1 spinal_JJ cord_NN1 ,_Y and_CC 1_MC1 liver_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   43 The local recurrences were treated with endoscopic and wide excision , the neck node metastases with neck dissection , and the distant metastases with chemotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   43 The_AT local_JJ recurrences_NN2 were_VBDR treated_VVN with_IW endoscopic_JJ and_CC wide_JJ excision_NN1 ,_Y the_AT neck_NN1 node_NN1 metastases_VVZ_NN2 with_IW neck_NN1 dissection_NN1 ,_Y and_CC the_AT distant_JJ metastases_NN2 with_IW chemotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   44 In addition to the 1 patient who presented with a liver metastasis and who received palliative local radiotherapy ( patient 5 ) , 6 patients received postoperative radiotherapy -- 3 for a local recurrence , 2 for a nodal metastasis , and 1 for a spinal cord metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   44 In_II31 addition_II32 to_II33 the_AT 1_MC1 patient_NN1 who_PNQS presented_VVD with_IW a_AT1 liver_NN1 metastasis_NN1 and_CC who_PNQS received_VVD palliative_JJ local_JJ radiotherapy_NN1 (_Y patient_NN1_JJ 5_MC )_Y ,_Y 6_MC patients_NN2 received_VVD_VVN postoperative_JJ radiotherapy_NN1 --_NN1 3_MC for_IF a_AT1 local_JJ recurrence_NN1 ,_Y 2_MC for_IF a_AT1 nodal_JJ metastasis_NN1 ,_Y and_CC 1_MC1 for_IF a_AT1 spinal_JJ cord_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   45 In addition to patient 5 , 3 patients received postoperative chemotherapy with dacarbazine for the treatment of 1 for a liver metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   45 In_II31 addition_II32 to_II33 patient_NN1_JJ 5_MC ,_Y 3_MC patients_NN2 received_VVD_VVN postoperative_JJ chemotherapy_NN1 with_IW dacarbazine_NN1 for_IF the_AT treatment_NN1 of_IO 1_MC1 for_IF a_AT1 liver_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   46 The patient who developed a spinal cord metastasis ( patient 3 ) did not receive chemotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   46 The_AT patient_NN1 who_PNQS developed_VVD a_AT1 spinal_JJ cord_NN1 metastasis_NN1 (_Y patient_NN1_JJ 3_MC )_Y did_VDD not_XX receive_VVI chemotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   47 Results At the final follow-up , 4 of the 10 patients were alive and without disease ( table ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   47 Results_NN2 At_II the_AT final_JJ_NN1 follow-up_NN1_JJ ,_Y 4_MC of_IO the_AT 10_MC patients_NN2 were_VBDR alive_JJ and_CC without_IW disease_NN1 (_Y table_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   48 Overall 2- and 5-year survival rates were 60 and 40% , respectively .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   48 Overall_JJ_RR 2-_NN1_JJ and_CC 5-year_JJ survival_NN1 rates_NN2 were_VBDR 60_MC and_CC 40%_NNU ,_Y respectively_RR ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   49 The 4 survivors at the last follow-up -- 3 men and 1 woman -- ranged in age from 35 to 60 years ( mean : 47.0 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   49 The_AT 4_MC survivors_NN2 at_II the_AT last_MD follow-up_JJ_NN1 --_NN1 3_MC men_NN2 and_CC 1_MC1 woman_NN1 --_NN1 ranged_VVN_VVD in_II age_NN1 from_II 35_MC to_II 60_MC years_NNT2 (_Y mean_VV0 :_Y 47.0_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   50 The 6 patients who died included 4 men and 2 women ; their ages ranged from 41 to 70 years ( mean : 54.3 ) Presenting features .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   50 The_AT 6_MC patients_NN2 who_PNQS died_VVD included_VVN_VVD 4_MC men_NN2 and_CC 2_MC women_NN2 ;_Y their_APPGE ages_NN2 ranged_VVN_VVD from_II 41_MC to_II 70_MC years_NNT2 (_Y mean_VV0 :_Y 54.3_MC )_Y Presenting_VVG features_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   51 Two of the 3 patients ( 67% ) who presented with a paranasal sinus melanoma died , compared with 4 of 7 patients ( 57% ) who had a primary nasal cavity tumor .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   51 Two_MC of_IO the_AT 3_MC patients_NN2 (_Y 67%_NNU )_Y who_PNQS presented_VVD with_IW a_AT1 paranasal_NN1_JJ@ sinus_NN1 melanoma_NN1 died_VVD ,_Y compared_VVN with_IW 4_MC of_IO 7_MC patients_NN2 (_Y 57%_NNU )_Y who_PNQS had_VHD a_AT1 primary_JJ nasal_JJ cavity_NN1 tumor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   52 Of the 2 patients who presented with a neck node metastasis , 1 was alive at 36 months .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   52 Of_IO the_AT 2_MC patients_NN2 who_PNQS presented_VVD with_IW a_AT1 neck_NN1 node_NN1 metastasis_NN1 ,_Y 1_MC1 was_VBDZ alive_JJ at_II 36_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   53 The other developed a spinal cord metastasis postoperatively , and he died 12 months after diagnosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   53 The_AT other_NN1@_JJ developed_VVD_VVN a_AT1 spinal_JJ cord_NN1 metastasis_NN1 postoperatively_RR ,_Y and_CC he_PPHS1 died_VVD 12_MC months_NNT2 after_II_CS diagnosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   54 The patient who presented with a liver metastasis died presented with a stage I tumor and 1 of the 2 who presented with a stage II tumor were still alive by the last follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   54 The_AT patient_NN1 who_PNQS presented_VVD with_IW a_AT1 liver_NN1 metastasis_NN1 died_VVD presented_VVD with_IW a_AT1 stage_NN1 I_MC1% tumor_NN1 and_CC 1_MC1 of_IO the_AT 2_MC who_PNQS presented_VVD with_IW a_AT1 stage_NN1 II_MC tumor_NN1 were_VBDR still_RR alive_JJ by_II the_AT last_MD follow-up_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   55 In contrast , the patients with stage III and stage IV disease both died 8 months after diagnosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   55 In_II contrast_NN1 ,_Y the_AT patients_NN2 with_IW stage_NN1 III_MC and_CC stage_NN1 IV_MC disease_NN1 both_RR died_VVD 8_MC months_NNT2 after_II_CS diagnosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   56 Initial treatment .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   56 Initial_JJ_NN1 treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   57 Three of the 4 patients who underwent medial maxillectomy survived to the last follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   57 Three_MC of_IO the_AT 4_MC patients_NN2 who_PNQS underwent_VVD medial_JJ maxillectomy_NN1 survived_VVD_VVN@ to_II the_AT last_MD follow-up_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   58 However , 2 of the survivors subsequently developed a local recurrence and 1 developed a neck node metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   58 However_RR ,_Y 2_MC of_IO the_AT survivors_NN2 subsequently_RR developed_VVN_VVD a_AT1 local_JJ recurrence_NN1 and_CC 1_MC1 developed_VVD_VVN a_AT1 neck_NN1 node_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   59 The patient who died had a liver metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   59 The_AT patient_NN1 who_PNQS died_VVD had_VHD a_AT1 liver_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   60 Of the 2 patients who underwent endoscopic excision , 1 died at 12 months of a spinal cord metastasis , and 1 was alive at 70 months .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   60 Of_IO the_AT 2_MC patients_NN2 who_PNQS underwent_VVD endoscopic_JJ excision_NN1 ,_Y 1_MC1 died_VVD_VVN@ at_II 12_MC months_NNT2 of_IO a_AT1 spinal_JJ cord_NN1 metastasis_NN1 ,_Y and_CC 1_MC1 was_VBDZ alive_JJ at_II 70_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   61 However , the survivor did develop a postoperative local recurrence .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   61 However_RR ,_Y the_AT survivor_NN1 did_VDD develop_VVI a_AT1 postoperative_JJ local_JJ recurrence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   62 None of the 3 patients who underwent wide local excision survived .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   62 None_PN of_IO the_AT 3_MC patients_NN2 who_PNQS underwent_VVD wide_JJ_RR@ local_JJ excision_NN1 survived_VVD ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   63 One developed a neck node metastasis and died at 30 months , and 2 developed a lung metastasis and died at 8 and 26 months .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   63 One_PN1 developed_VVD_VVN a_AT1 neck_NN1 node_NN1 metastasis_NN1 and_CC died_VVD at_II 30_MC months_NNT2 ,_Y and_CC 2_MC developed_VVD_VVN a_AT1 lung_NN1 metastasis_NN1 and_CC died_VVD at_II 8_MC and_CC 26_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   64 Sequelae .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   64 Sequelae_NN2_NP1@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   65 All 3 patients who developed a postoperative local recurrence were alive at the last follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   65 All_DB 3_MC patients_NN2 who_PNQS developed_VVD a_AT1 postoperative_JJ local_JJ recurrence_NN1 were_VBDR alive_JJ at_II the_AT last_MD follow-up_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   66 Of the 2 patients who at 24 months and the other died at 30 months .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   66 Of_IO the_AT 2_MC patients_NN2 who_PNQS at_II 24_MC months_NNT2 and_CC the_AT other_NN1@_JJ died_VVD_VVN@ at_II 30_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   67 All 4 patients who developed a distant metastasis postoperatively died within 26 months of diagnosis ( mean : 15 ; median 13 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   67 All_DB 4_MC patients_NN2 who_PNQS developed_VVD a_AT1 distant_JJ metastasis_NN1 postoperatively_RR died_VVD_VVN@ within_II 26_MC months_NNT2 of_IO diagnosis_NN1 (_Y mean_VV0 :_Y 15_MC ;_Y median_NN1_JJ 13_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   68 Radiotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   68 Radiotherapy_NN1_NP1@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   69 Of the 5 patients who had received a radical dose of radiation ( 50 Gy ) , 4 were alive at the last follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   69 Of_IO the_AT 5_MC patients_NN2 who_PNQS had_VHD received_VVN a_AT1 radical_JJ_NN1 dose_NN1 of_IO radiation_NN1 (_Y 50_MC Gy_NP1_JJ_NN1 )_Y ,_Y 4_MC were_VBDR alive_JJ at_II the_AT last_MD follow-up_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   70 Patient 3 received only 30 Gy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   70 Patient_NN1_JJ 3_MC received_VVD_VVN only_RR 30_MC Gy_JJ_NP1_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   71 Chemotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   71 Chemotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   72 All 4 patients who received chemotherapy died within 26 months ( mean : 14 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   72 All_DB 4_MC patients_NN2 who_PNQS received_VVD chemotherapy_NN1 died_VVD_VVN@ within_II 26_MC months_NNT2 (_Y mean_VV0 :_Y 14_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   73 Histopathology .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   73 Histopathology_NN1_NP1@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   74 There was a considerable difference in the number of diseased neck nodes seen on histopathology ( range : 10 to 20 ; mean : 15 ) compared with the number detected on palpation ( mean : 2 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   74 There_EX was_VBDZ a_AT1 considerable_JJ difference_NN1 in_II the_AT number_NN1 of_IO diseased_JJ neck_NN1 nodes_NN2 seen_VVN on_II histopathology_NN1 (_Y range_NN1_VV0@ :_Y 10_MC to_II 20_MC ;_Y mean_VV0 :_Y 15_MC )_Y compared_VVN_VVD@ with_IW the_AT number_NN1 detected_VVN_VVD on_II palpation_NN1 (_Y mean_VV0 :_Y 2_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   75 Discussion The 5-year survival rate of 40% in our study is comparable to the rates in studies reported by Snow et al n6 ( 38% ) and Manolidis and Donald n7 ( 30% ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   75 Discussion_NN1 The_AT 5-year_JJ_NNT1 survival_NN1 rate_NN1 of_IO 40%_NNU in_II our_APPGE study_NN1 is_VBZ comparable_JJ to_II the_AT rates_NN2 in_II studies_NN2 reported_VVN by_II Snow_NP1 et_RA21 al_RA22 n6_FO (_Y 38%_NNU )_Y and_CC Manolidis_NP1 and_CC Donald_NP1 n7_FO (_Y 30%_NNU )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   76 The primary indicator of a poor prognosis in our study was a distant metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   76 The_AT primary_JJ_NN1 indicator_NN1 of_IO a_AT1 poor_JJ prognosis_NN1 in_II our_APPGE study_NN1 was_VBDZ a_AT1 distant_JJ metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   77 All 5 patients with a distant metastasis died within 26 months despite adequate aggressive nature of this disease .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   77 All_DB 5_MC patients_NN2 with_IW a_AT1 distant_JJ metastasis_NN1 died_VVD_VVN@ within_II 26_MC months_NNT2 despite_II adequate_JJ aggressive_JJ nature_NN1 of_IO this_DD1 disease_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   78 None of the 4 survivors had a distant metastasis , and only 1 patient without a distant metastasis had died during follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   78 None_PN of_IO the_AT 4_MC survivors_NN2 had_VHD a_AT1 distant_JJ metastasis_NN1 ,_Y and_CC only_RR 1_MC1 patient_NN1_JJ without_IW a_AT1 distant_JJ metastasis_NN1 had_VHD died_VVN during_II follow-up_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   79 Other possibly poor prognostic factors included ( 1 ) older age , ( 2 ) a primary tumor location in a paranasal sinus , ( 3 ) an advanced tumor stage , ( 4 ) an external approach to surgery , and ( 5 ) the absence of adjuvant radiotherapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   79 Other_JJ_NN1@ possibly_RR poor_JJ prognostic_JJ factors_NN2 included_VVN_VVD (_Y 1_MC1 )_Y older_JJR age_NN1 ,_Y (_Y 2_MC )_Y a_AT1 primary_JJ_NN1 tumor_NN1 location_NN1 in_II a_AT1 paranasal_NN1_JJ@ sinus_NN1 ,_Y (_Y 3_MC )_Y an_AT1 advanced_JJ tumor_NN1 stage_NN1 ,_Y (_Y 4_MC )_Y an_AT1 external_JJ approach_NN1 to_II surgery_NN1 ,_Y and_CC (_Y 5_MC )_Y the_AT absence_NN1 of_IO adjuvant_JJ_NN1 radiotherapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   80 The mean age of the patients in our study ( 51.4 yr ) is consistent with that reported by others in the literature. ( n8 , n9 ) Also , the male preponderance and the disease predilection for patients older than 50 years ( n = 7 ) in our study population has been noted in other series. ( n10 , n11 ) For many reasons , including better immunosurveillance and a less virulent form of melanoma , younger patients generally have a better prognosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   80 The_AT mean_JJ age_NN1 of_IO the_AT patients_NN2 in_II our_APPGE study_NN1 (_Y 51.4_MC yr_NNU )_Y is_VBZ consistent_JJ with_IW that_DD1 reported_VVD_VVN by_II others_NN2 in_II the_AT literature._NNU (_Y n8_FO ,_Y n9_FO )_Y Also_RR ,_Y the_AT male_JJ_NN1 preponderance_NN1 and_CC the_AT disease_NN1 predilection_NN1 for_IF patients_NN2 older_JJR than_CSN 50_MC years_NNT2 (_Y n_ZZ1 =_FO 7_MC )_Y in_II our_APPGE study_NN1 population_NN1 has_VHZ been_VBN noted_VVN in_II other_JJ series._NNU (_Y n10_FO ,_Y n11_FO )_Y For_IF many_DA2 reasons_NN2 ,_Y including_II_VVG@ better_JJR immunosurveillance_NN1 and_CC a_AT1 less_RGR virulent_JJ form_NN1 of_IO melanoma_NN1 ,_Y younger_JJR patients_NN2 generally_RR have_VH0 a_AT1 better_JJR prognosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   81 The site of the primary tumor might also have been a prognostic factor , as 67% of those with a paranasal sinus melanoma died , tumor .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   81 The_AT site_NN1 of_IO the_AT primary_JJ_NN1 tumor_NN1 might_VM also_RR have_VHI been_VBN a_AT1 prognostic_JJ factor_NN1 ,_Y as_CSA_RG@ 67%_NNU of_IO those_DD2 with_IW a_AT1 paranasal_NN1_JJ@ sinus_NN1 melanoma_NN1 died_VVD ,_Y tumor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   82 The expected association between tumor stage at diagnosis and outcomes was seen in our study .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   82 The_AT expected_JJ association_NN1 between_II tumor_NN1 stage_NN1 at_II diagnosis_NN1 and_CC outcomes_NN2 was_VBDZ seen_VVN in_II our_APPGE study_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   83 In all , 4 patients experienced a neck node metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   83 In_II all_DB ,_Y 4_MC patients_NN2 experienced_VVD_VVN a_AT1 neck_NN1 node_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   84 Two of these were present at diagnosis , and 2 others occurred postoperatively .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   84 Two_MC of_IO these_DD2 were_VBDR present_JJ_NN1 at_II diagnosis_NN1 ,_Y and_CC 2_MC others_NN2 occurred_VVD postoperatively_RR ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   85 In both circumstances , 1 patient died during follow-up and 1 remained alive at the last follow-up ( table ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   85 In_II both_DB2 circumstances_NN2 ,_Y 1_MC1 patient_NN1 died_VVD_VVN@ during_II follow-up_NN1_JJ and_CC 1_MC1 remained_VVD_VVN alive_JJ at_II the_AT last_MD follow-up_NN1 (_Y table_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   86 Of the 2 patients who underwent endoscopic excision , 1 experienced a recurrence and the other a spinal cord metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   86 Of_IO the_AT 2_MC patients_NN2 who_PNQS underwent_VVD endoscopic_JJ excision_NN1 ,_Y 1_MC1 experienced_VVD_VVN a_AT1 recurrence_NN1 and_CC the_AT other_JJ_NN1@ a_AT1 spinal_JJ cord_NN1 metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   87 Four of the 6 patients who received postoperative radiotherapy were alive at the last follow-up .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   87 Four_MC of_IO the_AT 6_MC patients_NN2 who_PNQS received_VVD postoperative_JJ radiotherapy_NN1 were_VBDR alive_JJ at_II the_AT last_MD follow-up_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   88 The 3 patients who did not undergo adjuvant irradiation all died of a distant metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   88 The_AT 3_MC patients_NN2 who_PNQS did_VDD not_XX undergo_VVI adjuvant_JJ_NN1 irradiation_NN1 all_DB_RR@ died_VVD_VVN@ of_IO a_AT1 distant_JJ metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   89 Despite aggressive surgical treatment and postoperative radio- and chemotherapy , primary sinonasal malignant melanoma carries a poor prognosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   89 Despite_II aggressive_JJ surgical_JJ treatment_NN1 and_CC postoperative_JJ radio-_NN1_JJ and_CC chemotherapy_NN1 ,_Y primary_JJ_NN1 sinonasal_NN1_JJ@ malignant_NN1_JJ melanoma_NN1 carries_VVZ a_AT1 poor_JJ prognosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   90 All 9 patients who were aggressively treated developed either a recurrence or a local or distant metastasis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   90 All_DB 9_MC patients_NN2 who_PNQS were_VBDR aggressively_RR treated_VVN developed_VVN_JJ_VVD either_RR a_AT1 recurrence_NN1 or_CC a_AT1 local_JJ or_CC distant_JJ metastasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   91 One of the drawbacks of this study obviously is the small size of the patient sample , which precluded us from identifying statistically significant differences .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   91 One_MC1 of_IO the_AT drawbacks_NN2 of_IO this_DD1 study_NN1 obviously_RR is_VBZ the_AT small_JJ size_NN1 of_IO the_AT patient_JJ_NN1 sample_NN1 ,_Y which_DDQ precluded_VVD us_PPIO2 from_II identifying_VVG statistically_RR significant_JJ differences_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   92 However , in view of the paucity of literature on sinonasal to add to our knowledge of this disease , its treatment , and its prognosis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   92 However_RR ,_Y in_II31 view_II32 of_II33 the_AT paucity_NN1 of_IO literature_NN1 on_II sinonasal_NN1_JJ@ to_TO add_VVI to_II our_APPGE knowledge_NN1 of_IO this_DD1 disease_NN1 ,_Y its_Z' treatment_NN1 ,_Y and_CC its_Z' prognosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   93 Table .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   93 Table_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   94 Patient data and summary of findings pre-formatted table References ( n1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   94 Patient_JJ_NN1 data_NN and_CC summary_NN1 of_IO findings_NN2 pre-formatted_ZZ table_NN1 References_NN2 (_Y n1_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   95 ) Weber CO .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   95 )_Y Weber_NP1 CO_NP1_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   96 Chirurgische Ehrfahrungen und Untersuchungen , nebst zahlreichen Beobachtungen aus der chirurgischen Klinik und dem evangelischen Krahkenhause zu Bonn .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   96 Chirurgische_NP1@ Ehrfahrungen_NP1 und_NP1 Untersuchungen_NP1 ,_Y nebst_VV0_NN1 zahlreichen_JJ_NN1 Beobachtungen_NN1_NP1 aus_NN2_FW der_FU chirurgischen_JJ_NN1 Klinik_NN1_NP1 und_FW dem_FW evangelischen_JJ_NN1 Krahkenhause_NN1_NP1_VV0 zu_FW Bonn_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   97 Berlin : G. Reimer ; 1859. ( n2 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   97 Berlin_NP1 :_Y G._NP1 Reimer_NP1_NN1 ;_Y 1859._MC (_Y n2_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   98 ) Batsakis JG , Suarez P , El-Naggar AK .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   98 )_Y Batsakis_NP1@ JG_NP1 ,_Y Suarez_NP1 P_ZZ1_NP1@ ,_Y El-Naggar_NP1 AK_NP1_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0   99 Mucosal melanomas of the head and neck .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0   99 Mucosal_JJ melanomas_NN2 of_IO the_AT head_NN1 and_CC neck_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  100 Ann Otol Rhinol Laryngol 1998 ; 107(7):626-30. ( n3 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  100 Ann_NP1 Otol_NP1 Rhinol_NP1 Laryngol_NP1_NN1 1998_MC ;_Y 107(7):626-30._FO (_Y n3_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  101 ) Conley JJ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  101 )_Y Conley_NP1@ JJ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  102 Melanomas of the mucous membrane of the head and neck .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  102 Melanomas_NN2 of_IO the_AT mucous_NN1 membrane_NN1 of_IO the_AT head_NN1 and_CC neck_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  103 Laryngoscope 1989 ; 99(12):1248-54. ( n4 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  103 Laryngoscope_NN1_NP1@ 1989_MC ;_Y 99(12):1248-54._FO (_Y n4_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  104 ) Moore ES , Martin H. Melanoma of the upper respiratory tract and oral cavity .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  104 )_Y Moore_NP1 ES_NP1_FW ,_Y Martin_NP1 H._NP1 Melanoma_NP1_NN1@ of_IO the_AT upper_JJ respiratory_JJ tract_NN1 and_CC oral_JJ_NN1 cavity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  105 Cancer 1955 ; 8(6):1167-76. ( n5 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  105 Cancer_NN1 1955_MC ;_Y 8(6):1167-76._FO (_Y n5_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  106 ) Shah JP , Huvos AG , Strong EW .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  106 )_Y Shah_NP1 JP_NNA ,_Y Huvos_NP1_NN2 AG_FO ,_Y Strong_JJ_NP1@ EW_NN1_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  107 Mucosal melanomas of the head and neck .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  107 Mucosal_JJ melanomas_NN2 of_IO the_AT head_NN1 and_CC neck_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  108 Am J Surg 1977 ; 134(4):531-5. ( n6 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  108 Am_VBM J_NP1@ Surg_NP1_NN1 1977_MC ;_Y 134(4):531-5._FO (_Y n6_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  109 ) Snow GB , van der Esch EP , van Slooten EA .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  109 )_Y Snow_NP1 GB_NP1 ,_Y van_NP1 der_NP1 Esch_NP1 EP_NP1 ,_Y van_NP1 Slooten_NP1 EA_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  110 Mucosal melanomas of the head and neck .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  110 Mucosal_JJ melanomas_NN2 of_IO the_AT head_NN1 and_CC neck_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  111 Head Neck Surg 1978 ; 1(1):24-30. ( n7 melanoma of the head and neck : Review of the literature and report of 14 patients .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  111 Head_NN1_JJ@_VV0@ Neck_NN1 Surg_NN1_NP1_VV0 1978_MC ;_Y 1(1):24-30._FO (_Y n7_FO melanoma_NN1 of_IO the_AT head_NN1 and_CC neck_NN1_VV0@ :_Y Review_NN1 of_IO the_AT literature_NN1 and_CC report_NN1 of_IO 14_MC patients_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  112 Cancer 1997 ; 80(8):1373-86. ( n8 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  112 Cancer_NN1 1997_MC ;_Y 80(8):1373-86._FO (_Y n8_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  113 ) Hoyt DJ , Jordan T , Fisher SR .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  113 )_Y Hoyt_VV0_NN1 DJ_NN1 ,_Y Jordan_NP1 T_ZZ1_NP1@ ,_Y Fisher_NP1 SR_NNA ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  114 Mucosal melanoma of the head and neck .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  114 Mucosal_JJ melanoma_NN1 of_IO the_AT head_NN1 and_CC neck_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  115 Arch Otolaryngol Head Neck Surg 1989 ; 115(9):1096-9. ( n9 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  115 Arch_JJ_NN1 Otolaryngol_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 1989_MC ;_Y 115(9):1096-9._FO (_Y n9_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  116 ) Ravid JM , Esteves JA .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  116 )_Y Ravid_NP1@_JJ JM_NP1 ,_Y Esteves_NP1 JA_NP1_FW ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  117 Malignant melanoma of the nose and paranasal sinuses and juvenile melanoma of the nose .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  117 Malignant_JJ_NN1 melanoma_NN1 of_IO the_AT nose_NN1 and_CC paranasal_NN1_JJ@ sinuses_NN2_VVZ and_CC juvenile_JJ melanoma_NN1 of_IO the_AT nose_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  118 Arch Otolaryngol 1960 ; 72:431-44. ( n10 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  118 Arch_JJ_NN1 Otolaryngol_NN1_NP1 1960_MC ;_Y 72:431-44._MCMC (_Y n10_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  119 ) Harrison DE Malignant melanomata arising in the nasal mucous membrane .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  119 )_Y Harrison_NP1 DE_NP1 Malignant_NP1_JJ_NN1 melanomata_NN1 arising_VVG in_II the_AT nasal_JJ mucous_NN1 membrane_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  120 J Laryngol Otol 1976 ; 90(11):993-1005. ( n11 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  120 J_NP1@_ZZ1 Laryngol_NP1 Otol_NP1_NN1 1976_MC ;_Y 90(11):993-1005._FO (_Y n11_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  121 ) Prasad ML , Busam KJ , Patel SG , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  121 )_Y Prasad_NN1_NP1@ ML_NNU ,_Y Busam_NP1 KJ_NP1 ,_Y Patel_NP1 SG_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  122 Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  122 Clinicopathologic_JJ differences_NN2 in_II malignant_JJ_NN1 melanoma_NN1 arising_VVG in_II_RP@ oral_JJ squamous_JJ and_CC sinonasal_JJ@_NN1 respiratory_JJ mucosa_NN1 of_IO the_AT upper_JJ aerodigestive_JJ tract_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  123 Arch Pathol Lab Med 2003 ; 127(8):997-1002 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  123 Arch_JJ_NN1 Pathol_NN1 Lab_NN1 Med_VVD@_JJ 2003_MC ;_Y 127(8):997-1002_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  124 By Sudesh Kumar , MS , DNB , From the Department of Otolaryngology-Head and Neck Surgery , Postgraduate Institute of Medical Education and Research , Chandigarh , India ; Ashok K. Gupta , MS , DLO , MNAMS , From the Department of Otolaryngology-Head and Neck Surgery , India ; Budhi S. Yadav , BS , MD , Department of Radiotherapy , Postgraduate Institute of Medical Education and Research , Chandigarh , India and Sushmita Ghoshal , MD , DNB , Department of Radiotherapy , Postgraduate Institute of Medical Education and Research , Chandigarh , India Corresponding author : Dr. Sudesh Kumar , Department of Otolaryngology-Head and Neck Surgery , Postgraduate Institute of Medical Education and Research , Chandigarh , India 160012 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  124 By_II Sudesh_NP1 Kumar_NP1 ,_Y MS_NN1 ,_Y DNB_NP1 ,_Y From_II the_AT Department_NN1 of_IO Otolaryngology-Head_NN1 and_CC Neck_NN1_VV0@ Surgery_NN1 ,_Y Postgraduate_NN1 Institute_NN1 of_IO Medical_JJ Education_NN1 and_CC Research_NN1 ,_Y Chandigarh_NP1 ,_Y India_NP1 ;_Y Ashok_NP1 K._NP1 Gupta_NP1 ,_Y MS_NN1 ,_Y DLO_NP1_NN1 ,_Y MNAMS_NP2 ,_Y From_II the_AT Department_NN1 of_IO Otolaryngology-Head_NN1 and_CC Neck_NN1_VV0@ Surgery_NN1 ,_Y India_NP1 ;_Y Budhi_NP1 S._ZZ Yadav_NP1 ,_Y BS_NP1 ,_Y MD_NN1_NP1@ ,_Y Department_NN1 of_IO Radiotherapy_NP1_NN1 ,_Y Postgraduate_NN1 Institute_NN1 of_IO Medical_JJ Education_NN1 and_CC Research_NN1 ,_Y Chandigarh_NP1 ,_Y India_NP1 and_CC Sushmita_NP1 Ghoshal_NP1 ,_Y MD_NNA ,_Y DNB_NP1 ,_Y Department_NN1 of_IO Radiotherapy_NP1_NN1 ,_Y Postgraduate_NN1 Institute_NN1 of_IO Medical_JJ Education_NN1 and_CC Research_NN1 ,_Y Chandigarh_NP1 ,_Y India_NP1 Corresponding_JJ_VVG author_NN1 :_Y Dr._NNB Sudesh_NP1 Kumar_NP1 ,_Y Department_NN1 of_IO Otolaryngology-Head_NN1 and_CC Neck_NN1_VV0@ Surgery_NN1 ,_Y Postgraduate_NN1 Institute_NN1 of_IO Medical_JJ Education_NN1 and_CC Research_NN1 ,_Y Chandigarh_NP1 ,_Y India_NP1 160012_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  A    0  125 E-mail : **28;18671;TOOLONG or Sudeshkumar74@gmail.com
SENTPOS COCA_acad_wlp_2009_10_FILE##4080429 COCA  B    0  125 E-mail_NN1_VV0@ :_Y **28;18671;TOOLONG_FO or_CC Sudeshkumar74@gmail.com_FO
